hrs4r
 I want to donate

Come to IDIBGI and visit La Marató research!

23 March 2023
  • One of the visits will be led by Dr. Josep Comet, who will talk about research on prostate cancer (May 4), and the other will be led by Dr. Ramon Brugada, who will share a project on COVID-19 (May 9).
  • La Marató organizes this initiative of social return action, which demonstrates how the scientific community advances in the knowledge of several diseases thanks to the solidarity impulse.

The Fundació La Marató de TV3 promotes a large number of research projects thanks to the solidarity of citizens. The foundation and the research centers will present these projects in the new edition of the action "Visit the research of La Marató". The cycle is back on track after the stop caused by the outbreak of the pandemic in 2020. Two of the projects funded by La Marató will be presented by researchers from the Institute of Biomedical Research of Girona (IDIBGI) in two visits to the IDIBGI facilities, open to the public.

Sign up here: https://visitesrecercamarato.tv3.cat/ca/93-web-individual/1673-institut-dinvestigacio-biomedica-de-girona-dr-josep-trueta/info

Non-invasive Methodologies to Improve Prostate Cancer Diagnosis (May 4, 9 a.m.)

Biopsy is a necessary test for the definitive diagnosis of prostate cancer, but it uses an invasive method for the patient that is sometimes inefficient and has a high economic cost due to the fact that it requires more than one biopsy to reach the diagnosis. It is therefore important to advance in the use of non-invasive methodologies for the diagnosis of prostate cancer that allow the minimum number of biopsies to be performed, both for the quality of life of the patient and for the health cost, with the maximum possible efficiency.

This research project studies two non-invasive methodologies to improve the diagnosis of prostate cancer, which would allow patients with suspected more aggressive tumors to be treated more quickly and effectively. It would also reduce the number of biopsies in patients at low risk of having a significant tumor, thus avoiding unnecessary treatments.

Dr. Josep Comet, IDIBGI researcher and Head of the Urology Department of the Hospital Dr. Josep Trueta, participates in this research, which is co-led by Esther Llop, researcher at the University of Girona.

Progress in detecting the most serious complications of COVID-19 (May 9 visit at 10:00 a.m.)

What factors cause the most severe complications in COVID-19 patients and subsequent sequelae? The GINA-COVID project aims to investigate which genetic determinants of inflammation and thrombosis aggravate the disease and influence the occurrence of sequelae at 1 year. To do so, the genetic characteristics of these factors will be compared in patients who have had a severe form of COVID-19 with patients who have had a mild form of the disease.

The results may open the door to developing drugs to inhibit and treat these complications, and also identify which individuals are most predisposed to suffer a severe form of COVID-19.

The Cardiovascular Genetics research group at IDIBGI, headed by Dr. Ramon Brugada, who is also the head of the Cardiology Service of the Trueta and Santa Caterina Hospitals, is part of this project, which is led by the Hospital del Mar Medical Research Institute and in which the University of Vic and the IDIAP Jordi Gol also participate.

Citizenship return initiative

The project "Visita la recerca de La Marató" was born in 2015 with the aim of bringing research closer to the society that makes it possible, becoming a project of social return and transparency for the Fundació El Marató de TV3.

Do not hesitate, and sign up for the visits!

Image Credits: La Marató de TV3

Historical

Back to blog

About IDIBGI!

menu